ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ベラパミル塩酸塩

Verapamil Hydrochloride

HCID 62969
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
152-11-4
標準SMILES
COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl
InChIKey
DOQPXTMNIUCOSY-UHFFFAOYSA-N
分子式
C27H39ClN2O4
平均分子量
491.1 g/mol
単同位体質量
490.2598354

概要

Verapamil Hydrochloride is the hydrochloride form of Verapamil, which is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)

名称と識別子

優先名称
Verapamil Hydrochloride
IUPAC
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride
現地名
ベラパミル塩酸塩
英語名
(+/-)-Verapamil hydrochloride
分子式
C27H39ClN2O4
分子量
491.06

名称と別名

Verapamil hydrochloride152-11-4Verapamil HClVerelanCoveraIsoptin SRVerelan PMCalan SRVerapamili hydrochloridumDTXSID2034095Securon midManidon sr
名称をさらに表示
ワソランロシトールマゴチロン塩酸イプロベラトリル塩酸ベラパミルベラパミル塩酸塩5-[(3,4-ジメトキシフェネチル)メチルアミノ]-2-(3,4-ジメトキシフェニル)-2-イソプロピルバレロニトリル·塩酸塩ホルミトール2-(3,4-ジメトキシフェニル)-2-イソプロピル-5-(N-メチル-3,4-ジメトキシフェネチルアミノ)バレロニトリル·塩酸塩(±)-ベラパミル塩酸塩(USP)5-[(3,4-ジメトキシフェネチル)メチルアミノ]-2-(3,4-ジメトキシフェニル)-2-イソプロピルバレロニトリル塩酸塩(±)‐ベラパミル塩酸塩(USP)(±)-ベラパミル 塩酸塩ベラパミル 塩酸塩ベラパミル 塩酸塩 溶液ベラパミル塩酸塩 (JP17)2-(3,4-ジメトキシフェニル)-2-イソプロピル-5-(N-メチル-3,4-ジメトキシフェネチルアミノ)バレロニトリル・塩酸塩5-[(3,4-ジメトキシフェネチル)メチルアミノ]-2-(3,4-ジメトキシフェニル)-2-イソプロピルバレロニトリル・塩酸塩α-[3-[[2-(3,4-ジメトキシフェニル)エチル]メチルアミノ]プロピル]-3,4-ジメトキシ-α-(1-メ チルエチル)ベンゼンアセトニトリル塩酸塩manidoncordiloxizoptinhydrochloridelu20175RositolfinoptinHormitolMagotironVerapamil HCI

物性

構造計算による物性

極性表面積
64 Ų
水素結合供与体数
1
水素結合受容体数
6
回転可能結合数
13
重原子数
34
形式電荷
0
複雑度
606

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section208.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
142 °C · 142 °C (dec.)(lit.)
比重(密度)
1.0596 · 1.0596 (rough estimate)
屈折率
1.629 · 1.6290 (estimate)
闪点
9 ℃ · 9℃
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: >30 mg/mL
酸解離定数(Pka)
8.6 · 8.6(at 25℃)
外見
個体
色
白い
水溶解度
溶ける
Merck
14 · 14,9950
BRN
3647093 · 3647093
BCS Class
2 · 2
安定性
-20 °C · DMSO 溶液または蒸留水で -20°C で最大 3 か月間保存できます。
InChI
1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Danger

H301+H311 (10.4%): Toxic if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]

P260, P261, P262, P264, P264+P265, P270, P271, P273, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P319, P320, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 270 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

危険有害性情報

Regulatory InformationVerapamil hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (99.6%)

毒性情報

Treatment · 1 件

Treatment of overdosage should be supportive. Beta-adrenergic stimulation or parenteral administration of calcium solutions may increase calcium ion flux across the slow channel and have been used effectively in treatment of deliberate overdosage with verapamil. In a few reported cases, overdose with calcium channel blockers has been associated with hypotension and bradycardia, initially refractory to atropine but becoming more responsive to this treatment when the patients received large doses (close to 1 gram/hour for more than 24 hours) of calcium chloride. Verapamil cannot be removed by hemodialysis. Clinically significant hypotensive reactions or high degree AV block should be treated with vasopressor agents or cardiac pacing, respectively. Asystole should be handled by the usual measures including cardiopulmonary resuscitation. (L1712)

化学と産業

薬理情報

Metabolism/MetabolitesRoute of Elimination: Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug. Half Life: 2.8-7.4 hours
FDA Pharmacological Classification · 4 件

VERAPAMIL HCI

Calcium Channel Blocker [EPC]; Calcium Channel Antagonists [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

VERAPAMIL HYDROCHLORIDE

Calcium Channel Blocker [EPC]; Calcium Channel Antagonists [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

MeSH Pharmacological Classification · 3 件

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Drugs used to cause dilation of the blood vessels.

用途と製造

UsesDrug used for the treatment of hypertension, angina, and cluster headache prophylaxis.
応用分野 · 5 件

用途薬理・生理作用研究用。

用途カルシウム拮抗剤です。L 型 電位依存性カルシウムチャネルのV 部位に結 合し、細胞内へのカルシウムイオン流入を抑 制する作用を示します。

用途カルシウム拮抗剤です。L型 電位依存性カルシウムチャネルのV部位に結 合し、細胞内へのカルシウムイオン流入を抑 制する作用を示します。

関連反応

5 件
反応記録を作成
HRID 324915 の反応式
HRID 324915反応物として
HRID 1249656 の反応式
HRID 1249656反応物として
HRID 1408273 の反応式
HRID 1408273反応物として
HRID 1456876 の反応式
HRID 1456876反応物として
HRID 2414989 の反応式
HRID 2414989反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
d-365hydrochloride
Ranvera mrNSC-272366NSC-657799V3888OEY5RNSC657799LU-20175(+-)-Verapamil hydrochlorideDTXCID0014095

データベース識別子

CAS
152-11-4、23313-68-0
PubChem CID
62969
DTXSID
DTXSID2034095
ChEMBL
CHEMBL1280
UNII
V3888OEY5R
EC Number
205-800-5、245-579-2、862-789-5
InChIKey
DOQPXTMNIUCOSY-UHFFFAOYSA-N
SMILES
Cl.COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC
CAS データベース
152 · 152-11-4(CAS DataBase Reference)

化学的性質

化学的特性white to off-white powder

Health Effects · 1 件

Cardiovascular: angina pectoris, AV block (2° & 3°), atrioventricular dissociation, CHF, pulmonary edema, chest pain, claudication, myocardial infarction, palpitations, purpura (vasculitis), syncope. Digestive system: diarrhea, dry mouth, gastrointestinal distress, gingival hyperplasia. Hemic and lymphatic: ecchymosis or bruising. Nervous system: cerebrovascular accident, confusion, equilibrium disorders, insomnia, muscle cramps, psychotic symptoms, shakiness, somnolence, extrapyramidal symptoms. Skin: arthralgia and rash, exanthema, hair loss, hyperkeratosis, macules, sweating, urticaria, Stevens-Johnson syndrome, erythema multiforme. Special senses: blurred vision, tinnitus. Urogenital: gynecomastia, galactorrhea/hyperprolactinemia, increased urination, spotty menstruation, impotence.

Exposure RoutesOrally, 90‰ЫТ100% of Verapamil is absorbed. Intravenous.
Toxicity Summary · 1 件

Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known.

Signs and Symptoms · 1 件

The resultant inhibition of the contractile processes of the myocardial smooth muscle cells leads to dilation of the coronary and systemic arteries,improved oxygen delivery to the myocardial tissue, and decreased total peripheral resistance, systemic blood pressure, and afterload.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Verapamil hydrochloride

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataLD50: 8 mg/kg (Intravenous, Mouse) (A308)

安全データ

F
8-10
wgk
3
rtecs
YV8320000
ridadr
UN 2811 6.1/PG 3
毒性
LD50 in mice, rats (mg/kg): 7.6, 16 i.v.; 68, 107 s.c.; 68, 67 i.p.; 163, 114 orally (Haas, Hrtfelder)
hs_code
2926909090
risk_code
25-23/24/25-39/23/24/25-11
hazard_code
T,F
safety_code
45-36/37/39-36/37-16
hazard_class
6.1(b)
packing_group
III
毒劇物取締法
劇物
Hazard Classifications
Acute Tox. 3 OralAquatic Chronic 2
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
危険度評価(NFPA 704基準/消防庁データ)
人的[青]=2

使用analgesic, antipyretic

一般的な説明Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Verapamil hydrochloride is a calcium channel blocker used commonly for the management of angina, supra-ventricular tachyarrhythmia, hypertension, migraine and atrial tachyarrhythmias.

上流・下流製品情報

上流原料

3,4-ジメトキシベンジル シアニド2-ブロモプロパングアイアコール